CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

CRE In the News

FDA Still Balking At 1988 Drug Law: Tool To Fight Counterfeiting Of Medicine Still In Limbo
Despite its dire warnings about counterfeit prescription drugs flooding into the United States, the Food and Drug Administration has never used a "valuable tool" Congress gave it nearly 16 years ago to combat the problem. ...Bruce Levinson, director of the Pharmaceutical Policy Project at the Center for Regulatory Effectiveness, said he does not think partisan ideology influenced the FDA's shift in position. Levinson noted that President Reagan, a conservative, signed the 1988 measure, but that most of the delays came during the more liberal Clinton administration.... The center wants the requirement to take effect April 1 as scheduled.
The Hartford Courant, February 1, 2004